EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne–Bonn region: a retrospective cohort study

Isabelle Suárez, Dominic Rauschning, Cora Schüller, Anna Hagemeier, Melanie Stecher, Clara Lehmann, Philipp Schommers, Stefan Schlabe, Jörg-Janne Vehreschild, Carolin Koll, Carolynne Schwarze-Zander, Jan-Christian Wasmuth und 5 weitere

Infection · 2024

DOI: 10.1007/s15010-024-02215-y ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Infection, 2024. Verfasst von Isabelle Suárez und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germa…. Hauptthemen laut MEDLINE: HIV Infections, Tuberculosis, Coinfection. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum für Infektionsforschung, German Federal Ministry of Education and Research (BMBF), Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The risk of developing active tuberculosis (TB) is considerably increased in people living with HIV/AIDS (PLWH). However, incidence of HIV/TB coinfection is difficult to assess as surveillance data are lacking in many countries. Here, we aimed to perform a quantitative analysis of HIV/TB coinfections within the Cologne/Bonn HIV cohort and to determine risk factors for active TB.

Methods

We systematically evaluated data of patients with HIV/TB coinfection between 2006 and 2017. In this retrospective analysis, we compared HIV/TB-coinfected patients with a cohort of HIV-positive patients. The incidence density rate (IDR) was calculated for active TB cases at different time points.

Results

During 2006–2017, 60 out of 4673 PLWH were diagnosed with active TB. Overall IDR was 0.181 cases/100 patient-years and ranged from 0.266 in 2006–2009 to 0.133 in 2014–2017. Patients originating from Sub-Saharan Africa had a significantly ( p < 0.001) higher IDR (0.694/100 patient-years of observation, 95% CI [0.435–1.050]) in comparison to patients of German origin (0.053/100 patient-years of observation, 95% CI [0.028–0.091]). In terms of TB-free survival, individuals originating from countries with a TB incidence higher than 10/100,000 exhibited a markedly reduced TB-free survival compared to those originating from regions with lower incidence ( p < 0.001). In 22 patients, TB and HIV infection were diagnosed simultaneously.

Conclusion

Overall, we observed a decline in the incidence density rate (IDR) of HIV/TB coinfections between 2006 and 2017. Patients originating from regions with high incidence bear a higher risk of falling ill with active TB. For PLWH born in Germany, the observed risk of active TB appears to be lower compared to other groups within the cohort. These findings should be considered when developing TB containment and screening strategies for PLWH in low-incidence countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsTuberculosisCoinfectionHumansRetrospective StudiesIncidenceRisk FactorsMaleFemaleAdultGermanyMiddle AgedYoung AdultCohort Studies

Stichwörter der Autor:innen

Antiretroviral therapyGermanyHIVImmigrantsTB low-burden countryTuberculosis

Autor:innen und Institutionen

  • Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany.
  • Department IB of Internal Medicine, Bundeswehrzentralkrankenhaus Koblenz, Koblenz, Germany.
  • Medical Faculty and University Hospital Cologne, Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.
  • Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
  • Department of Medicine I, University Hospital Bonn, Bonn, Germany.

Förderung

  • Deutsches Zentrum für Infektionsforschung
  • German Federal Ministry of Education and Research (BMBF)
  • Deutsche Forschungsgemeinschaft
  • Innovative Medicines Initiative 2 Joint Undertaking
  • Federal Joint Committee
  • Universitätsklinikum Köln

Zitieren

APA

Suárez, I., Rauschning, D., Schüller, C., Hagemeier, A., Stecher, M., Lehmann, C., Schommers, P., Schlabe, S., Vehreschild, J. J., Koll, C., Schwarze-Zander, C., Wasmuth, J. C., Klingmüller, A., Rockstroh, J. K., Fätkenheuer, G., Boesecke, C., & Rybniker, J. (2024). Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne–Bonn region: a retrospective cohort study. Infection. https://doi.org/10.1007/s15010-024-02215-y

Vancouver

Suárez I, Rauschning D, Schüller C, Hagemeier A, Stecher M, Lehmann C, et al. Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne–Bonn region: a retrospective cohort study. Infection. 2024. doi:10.1007/s15010-024-02215-y

BibTeX
@article{Surez2024,
  author = {Suárez, Isabelle and Rauschning, Dominic and Schüller, Cora and Hagemeier, Anna and Stecher, Melanie and Lehmann, Clara and Schommers, Philipp and Schlabe, Stefan and Vehreschild, Jörg-Janne and Koll, Carolin and Schwarze-Zander, Carolynne and Wasmuth, Jan-Christian and Klingmüller, Angela and Rockstroh, Jürgen Kurt and Fätkenheuer, Gerd and Boesecke, Christoph and Rybniker, Jan},
  title = {Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne–Bonn region: a retrospective cohort study},
  journal = {Infection},
  year = {2024},
  doi = {10.1007/s15010-024-02215-y}
}
Kostenlos starten →